N-Glycan Profile and Kidney Disease in Type 1 Diabetes.

Bermingham, Mairead L; Colombo, Marco; McGurnaghan, Stuart J; Blackbourn, Luke A K; Vučković, Frano; Pučić Baković, Maja; Trbojević-Akmačić, Irena; Lauc, Gordan et al. · Diabetes Care · 2018

retrospective_cohort · Level III

Where this comes from

Abstract

Poorer glycemic control in type 1 diabetes may alter N-glycosylation patterns on circulating glycoproteins, and these alterations may be linked with diabetic kidney disease (DKD). We investigated associations between N-glycans and glycemic control and renal function in type 1 diabetes. Using serum samples from 818 adults who were considered to have extreme annual loss in estimated glomerular filtration rate (eGFR; i.e., slope) based on retrospective clinical records, from among 6,127 adults in the Scottish Diabetes Research Network Type 1 Bioresource Study, we measured total and IgG-specific N-glycan profiles. This yielded a relative abundance of 39 total (GP) and 24 IgG (IGP) N-glycans. Linear regression models were used to investigate associations between N-glycan structures and HbA<sub>1c</sub>, albumin-to-creatinine ratio (ACR), and eGFR slope. Models were adjusted for age, sex, duration of type 1 diabetes, and total serum IgG. Higher HbA<sub>1c</sub> was associated with a lower relative abundance of simple biantennary N-glycans and a higher relative abundance of more complex structures with more branching, galactosylation, and sialylation (GP12, 26, 31, 32, and 34, and IGP19 and 23; all <i>P</i> < 3.79 × 10<sup>-4</sup>). Similar patterns were seen for ACR and greater mean annual loss of eGFR, which were also associated with fewer of the simpler N-glycans (all <i>P</i> < 3.79 × 10<sup>-4</sup>). Higher HbA<sub>1c</sub> in type 1 diabetes is associated with changes in the serum N-glycome that have elsewhere been shown to regulate the epidermal growth factor receptor and transforming growth factor-β pathways that are implicated in DKD. Furthermore, N-glycans are associated with ACR and eGFR slope. These data suggest that the role of altered N-glycans in DKD warrants further investigation.

Medical subject headings